Press "Enter" to skip to content

Growth disparities in uterine leiomyomas associated with MED12 mutation

Growth disparities in uterine leiomyomas associated with MED12 mutation
Uterine leiomyoma is the most common benign estrogen (E)-dependent tumor in women of reproductive age. Approximately 25% of women are affected and the cumulative incidence is 70% of women by the age of 50 years. In addition, this tumor is more prevalent at younger ages, and is more common in African-American women (73%) compared to White women (45%). Uterine leiomyoma comprises smooth muscle cells derived from the myometrium and an extracellular matrix rich in collagen, fibronectin, and proteoglycans.
Source: fertstert.org

Be First to Comment

This site uses Akismet to reduce spam. Learn how your comment data is processed.